Like I don't even, I remember when we first interviewed, when I first interviewed you, I just started using it and I was like, I was like, eh, this is going to, this is going to take some like a learning curve
J., Blakemore, A
T., Sonne, N., Andreassen, K
Importantly, preclinical studies showed that weight reduction occurred particularly in abdominal adipose tissue, the visceral fat depot most strongly associated with metabolic health risks
Research Evidence Comparison# Mazdutide Research# Mazdutide has the largest Phase 3 evidence base of any GLP-1/glucagon dual agonist, with seven trials across the GLORY (obesity) and DREAMS (T2D) programs